公开(公告)号：US20210106685A1

公开(公告)日：2021-04-15

申请号：US17132038

申请日：2020-12-23

Applicant: Boehringer Ingelheim Vetmedica GmbH

Inventor： Michael AVEN ,  Balazs ALBRECHT ,  Benjamin FRANZMANN ,  Matthias HAUSMANN ,  Janine LAMAR ,  Ingo LANG

IPC: A61K47/02 ,  A61K9/00 ,  A61K9/08 ,  A61P11/00 ,  A61K31/58 ,  A61K47/10

Abstract: The disclosure relates to the field of medicine, in particular to the field of veterinary medicine. The disclosure relates to a pharmaceutical (medicament) formulation of glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof.

公开(公告)号：US20190262329A1

公开(公告)日：2019-08-29

申请号：US16406918

申请日：2019-05-08

Applicant: Boehringer Ingelheim Vetmedica GmbH

Inventor： Balazs ALBRECHT ,  Michael AVEN ,  Janine LAMAR

IPC: A61K31/46 ,  A61K45/06 ,  A61K9/00 ,  A61K31/58 ,  A61M15/00 ,  A61K35/06

Abstract: The disclosure relates to the field of medicine, in particular to the field of veterinary medicine. The disclosure specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.

公开(公告)号：US20150366855A1

公开(公告)日：2015-12-24

申请号：US14740582

申请日：2015-06-16

Applicant: Boehringer Ingelheim Vetmedica GmbH

Inventor： Balazs ALBRECHT ,  Michael AVEN ,  Janine LAMAR

IPC: A61K31/46 ,  A61K35/06 ,  A61M15/00 ,  A61K31/58

CPC classification number: A61K31/46 ,  A61K9/0073 ,  A61K9/008 ,  A61K31/58 ,  A61K35/06 ,  A61K45/06 ,  A61M15/009 ,  A61M2250/00 ,  A61K2300/00

Abstract: The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.

Abstract translation: 本发明涉及医学领域，特别涉及兽医领域。 本发明具体涉及毒蕈碱拮抗剂（包括长效毒蕈碱拮抗剂（LAMAs）），用于治疗气道疾病，例如肺部疾病，优选复发性气道阻塞（RAO），夏季牧场相关阻塞性肺病（SPAOPD）和炎性气道 动物中的疾病（IAD），优选马，如马。

公开(公告)号：US20180153907A1

公开(公告)日：2018-06-07

申请号：US15889307

申请日：2018-02-06

Applicant: Boehringer Ingelheim Vetmedica GmbH

Inventor： Balazs ALBRECHT ,  Michael AVEN ,  Janine LAMAR ,  Ingo LANG

IPC: A61K31/58 ,  A61K9/00

CPC classification number: A61K31/58 ,  A61K9/0073 ,  A61K9/0078 ,  A61K9/008

Abstract: Methods of treating airway diseases in equines include administering to an equine an effective amount of ciclesonide or a pharmaceutically acceptable salt thereof or a composition including ciclesonide or a pharmaceutically acceptable salt thereof.

公开(公告)号：US20150313918A1

公开(公告)日：2015-11-05

申请号：US14654009

申请日：2013-12-18

Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH

Inventor： Balazs ALBRECHT ,  Michael AVEN ,  Janine LAMAR ,  Ingo LANG

IPC: A61K31/58 ,  A61K9/00

CPC classification number: A61K31/58 ,  A61K9/0073 ,  A61K9/0078 ,  A61K9/008

Abstract: The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof, for the treatment of airway disease in horses, such as pulmonary disease, preferably recurrent airway obstruction (RAO), Summer Pasture Associated Obstructive Pulmonary disease (SPAOPD), and inflammatory airway disease (IAD).

Abstract translation: 本发明涉及医学领域，特别涉及兽医领域。 本发明涉及用于治疗马中气道疾病的糖皮质激素，特别是环索奈德或其药学上可接受的衍生物，例如肺部疾病，优选复发性气道阻塞（RAO），夏季牧场相关阻塞性肺病（SPAOPD）和炎性气道 疾病（IAD）。

公开(公告)号：US20170079988A1

公开(公告)日：2017-03-23

申请号：US15292765

申请日：2016-10-13

Applicant: Boehringer Ingelheim Vetmedica GmbH

Inventor： Balazs ALBRECHT ,  Michael AVEN ,  Janine LAMAR ,  Ingo LANG

IPC: A61K31/58 ,  A61K9/00

CPC classification number: A61K31/58 ,  A61K9/0073 ,  A61K9/0078 ,  A61K9/008

Abstract: The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative or salt thereof, for the treatment of airway disease in horses, such as pulmonary disease, preferably recurrent airway obstruction (RAO), Summer Pasture Associated Obstructive Pulmonary disease (SPAOPD), and inflammatory airway disease (IAD).

公开(公告)号：US20170007593A1

公开(公告)日：2017-01-12

申请号：US15274259

申请日：2016-09-23

Applicant: Boehringer Ingelheim Vetmedica GmbH

Inventor： Balazs ALBRECHT ,  Michael AVEN ,  Janine LAMAR

IPC: A61K31/46 ,  A61M15/00 ,  A61K9/00 ,  A61K31/58 ,  A61K45/06

CPC classification number: A61K31/46 ,  A61K9/0073 ,  A61K9/008 ,  A61K31/58 ,  A61K35/06 ,  A61K45/06 ,  A61M15/009 ,  A61M2250/00 ,  A61K2300/00

Abstract: The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.

Abstract translation: 本发明涉及医学领域，特别涉及兽医领域。 本发明具体涉及毒蕈碱拮抗剂（包括长效毒蕈碱拮抗剂（LAMAs）），用于治疗气道疾病，例如肺部疾病，优选复发性气道阻塞（RAO），夏季牧场相关阻塞性肺病（SPAOPD）和炎性气道 动物中的疾病（IAD），优选马，如马。